Synthetic Red Blood Cell-Specific Glycolytic Intermediate 2,3-Diphosphoglycerate (2,3-DPG) Inhibits Plasmodium falciparum Development In Vitro

Overview of attention for article published in Frontiers in Cellular and Infection Microbiology, March 2022

Altmetric Badge

Mentioned by

twitter: 3 X users

Citations

dimensions_citation: 4 Dimensions

Readers on

mendeley: 12 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 7 X posts from 3 X users, with an upper bound of 10,131 followers.

RT @bloodSparasites: Synthetic Red Blood Cell-Specific Glycolytic Intermediate 2,3-Diphosphoglycerate (2,3-DPG) Inhibits #Plasmodium falcip…

08 Apr 2022

Reply Repost Favourite

Synthetic Red Blood Cell-Specific Glycolytic Intermediate 2,3-Diphosphoglycerate (2,3-DPG) Inhibits #Plasmodium falciparum Development In Vitro https://t.co/Y53cbaezzg PubMed

06 Apr 2022

Reply Repost Favourite

RT @MalariaPapers: Synthetic Red Blood Cell-Specific Glycolytic Intermediate 2,3-Diphosphoglycerate (2,3-DPG) Inhibits Plasmodium falciparu…

06 Apr 2022

Reply Repost Favourite

Synthetic Red Blood Cell-Specific Glycolytic Intermediate 2,3-Diphosphoglycerate (2,3-DPG) Inhibits Plasmodium falciparum Development In Vitro https://t.co/FmNAAq5JaI

06 Apr 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 3 additional X posts.